These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8697305

  • 1. Accessibility of human apolipoprotein B-100 epitopes in insulin-dependent diabetes: relation with the surface lipid environment of atherogenic particles.
    Ziegler O, Méjean L, Igau B, Fruchart JC, Drouin P, Fiévet C.
    Diabetes Metab; 1996 Jun; 22(3):179-84. PubMed ID: 8697305
    [Abstract] [Full Text] [Related]

  • 2. Insulin-resistance and lipoprotein abnormalities.
    Fruchart JC.
    Diabete Metab; 1991 May; 17(1 Pt 2):244-8. PubMed ID: 1936484
    [Abstract] [Full Text] [Related]

  • 3. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B, Igau B, Ziegler O, Crea T, Fruchart JC, Drouin P, Fievet C.
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein heterogeneity and its effect on apolipoprotein assays.
    Fruchart JC.
    Scand J Clin Lab Invest Suppl; 1990 Apr; 198():51-7. PubMed ID: 2111936
    [Abstract] [Full Text] [Related]

  • 5. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
    Igau B, Lestavel S, Clavey V, Slomianny C, Drouin P, Bresson R, Fruchart JC, Duriez P, Fiévet C.
    Atherosclerosis; 1996 Feb; 120(1-2):209-19. PubMed ID: 8645362
    [Abstract] [Full Text] [Related]

  • 6. Apolipoprotein assays: methodological considerations and studies in non-insulin-dependent diabetes treated by diet, glibenclamide and insulin.
    Billingham MS, Milles JJ, Green A, Bailey CJ, Hall RA.
    Scand J Clin Lab Invest; 1989 May; 49(3):239-47. PubMed ID: 2500699
    [Abstract] [Full Text] [Related]

  • 7. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J, Nakajima K, Nohara A, Kawashiri M, Yagi K, Inazu A, Koizumi J, Yamagishi M, Mabuchi H.
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein-B subclasses as acceptors of cholesteryl esters transferred by CETP.
    Lee DM, Alaupovic P, Knight-Gibson C, Bagdade JD.
    Eur J Clin Invest; 2008 Oct; 38(10):734-42. PubMed ID: 18761668
    [Abstract] [Full Text] [Related]

  • 9. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH.
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Matsumoto K, Fujita N, Nakamura K, Senoo T, Tominaga T, Ueki Y.
    Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
    [Abstract] [Full Text] [Related]

  • 11. The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapy.
    O'Neal DN, Hew FL, Best JD, Alford F.
    Growth Horm IGF Res; 1999 Jun; 9(3):165-73. PubMed ID: 10502452
    [Abstract] [Full Text] [Related]

  • 12. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R, Mahajan M, Singh B, Bal BS, Kant R.
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein B gene variants are involved in the determination of blood glucose and lipid levels in patients with non-insulin dependent diabetes mellitus.
    Duman BS, Oztürk M, Yilmazer S, Cağatay P, Hatemi H.
    Cell Biochem Funct; 2006 Sep; 24(3):261-7. PubMed ID: 16634094
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.